Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms

Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer...

Full description

Saved in:
Bibliographic Details
Published inCancer letters Vol. 398; pp. 24 - 36
Main Authors Wang, Lili, Wu, Huanwen, Wang, Li, Zhang, Hui, Lu, Junliang, Liang, Zhiyong, Liu, Tonghua
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 10.07.2017
Elsevier Limited
Subjects
EMT
CM
EMT
ECM
PCC
ASC
Online AccessGet full text

Cover

Loading…
Abstract Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial–mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with our in vitro experiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer. •The expression and distribution of Asporin in pancreatic cancer are confirmed.•Asporin promotes invasion and migration of pancreatic cancer by regulating the EMT.•Asporin exerts its biological roles through autocrine and paracrine manners.•Asporin may be a potential prognostic biomarker for pancreatic cancer.
AbstractList Abstract Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial–mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with our in vitro experiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer.
Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial–mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with our in vitro experiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer. •The expression and distribution of Asporin in pancreatic cancer are confirmed.•Asporin promotes invasion and migration of pancreatic cancer by regulating the EMT.•Asporin exerts its biological roles through autocrine and paracrine manners.•Asporin may be a potential prognostic biomarker for pancreatic cancer.
Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial-mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with ourin vitroexperiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer.
Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial-mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with our in vitro experiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer.Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial-mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with our in vitro experiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer.
Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix (ECM) protein, is highly expressed in cancer-associated fibroblasts (CAFs). Asporin expression in PSCs and its roles in PSC-pancreatic cancer cell (PCC) interaction remain unclear. The present study firstly showed that Asporin is highly expressed in activated PSCs and is involved in PSC-mediated invasion and migration of PCCs. Exogenous Asporin interacted with the transmembrane receptor CD44 on PCCs to activate NF-κB/p65 and promoted the epithelial-mesenchymal transition (EMT) in PCCs. Furthermore, AKT and ERK pathways participated in Asporin/CD44-induced NF-κB/p65 activation in pancreatic cancer. Asporin had similar effects on PCCs via an autocrine mechanism. Consistent with our in vitro experiments, we showed that Asporin in peritumoral stroma of pancreatic cancer tissues was associated with poor clinical outcome. In conclusion, this is the first study to show that Asporin promotes EMT, invasion, and migration of PCCs by activating CD44-AKT/ERK-NF-κB pathway in paracrine and autocrine manners. Moreover, our results indicate that Asporin may be a prognostic marker and suggest that targeting the tumor microenvironment represents a promising therapeutic strategy in pancreatic cancer.
Author Wu, Huanwen
Zhang, Hui
Liang, Zhiyong
Wang, Lili
Wang, Li
Liu, Tonghua
Lu, Junliang
Author_xml – sequence: 1
  givenname: Lili
  surname: Wang
  fullname: Wang, Lili
– sequence: 2
  givenname: Huanwen
  surname: Wu
  fullname: Wu, Huanwen
– sequence: 3
  givenname: Li
  surname: Wang
  fullname: Wang, Li
– sequence: 4
  givenname: Hui
  surname: Zhang
  fullname: Zhang, Hui
– sequence: 5
  givenname: Junliang
  surname: Lu
  fullname: Lu, Junliang
– sequence: 6
  givenname: Zhiyong
  surname: Liang
  fullname: Liang, Zhiyong
  email: liangzhiyong1220@yahoo.com
– sequence: 7
  givenname: Tonghua
  surname: Liu
  fullname: Liu, Tonghua
  email: Tonghua_liu@163.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28400334$$D View this record in MEDLINE/PubMed
BookMark eNqVkl9rFDEUxQep2D_6DUQCvtSHWW8myc6MiFBK_QMVH6zPIZO5s5s1k4xJprCfyS9pdrdFKEjxKVz4nXPDOfe0OHLeYVG8pLCgQJdvNwutnMW0qIDWC-ALAPqkOKFNXZV128BRcQIMeMkaJo6L0xg3ACB4LZ4Vx1XDARjjJ8Xvizj5YByZgh99wkgm5XRAlYwmeYHGQDRaS4y7VdF4R5TryWhWIRN56rYk4Gq2eXIrktZIcDL5sUbZMvlyxIhOr7ejsiQF5aLZy86vvt68yXjw82pNOp_WRM3J6_wT3G-YVFCHaUS9Vs7EMT4vng7KRnxx954VPz5e3Vx-Lq-_ffpyeXFdarHkqazZwGgHnHEFqhl6rllFB2xRAHZDJzQ0bdUAb7sBoRNKtA2rWaVV1VPOemRnxfnBN2fya8aY5GjiLgTl0M9R0qapQVAmqoy-foBu_Bxc_l2mWiEA-LLO1Ks7au5G7OUUzKjCVt7XkIF3B0AHH2PAQWqT9gHnzIyVFOSuc7mRh87lrnMJXObOs5g_EN_7PyL7cJBhjvLWYJBRm9wV9iagTrL35n8NtDXOaGV_4hbj3yBkrCTI77tr3B0jrRlUDJbZ4P2_DR7f_wc0UPQk
CitedBy_id crossref_primary_10_3892_mmr_2021_12459
crossref_primary_10_1007_s13300_018_0509_y
crossref_primary_10_1016_j_heliyon_2020_e05632
crossref_primary_10_1002_jor_26039
crossref_primary_10_3390_genes14061251
crossref_primary_10_1016_j_matbio_2022_04_005
crossref_primary_10_1016_j_prp_2023_154462
crossref_primary_10_1111_pin_13211
crossref_primary_10_1096_fj_202100111R
crossref_primary_10_3389_fonc_2021_646399
crossref_primary_10_1002_1878_0261_12399
crossref_primary_10_1016_j_bbcan_2023_189029
crossref_primary_10_1016_j_bbcan_2024_189225
crossref_primary_10_3390_ijms242115906
crossref_primary_10_1038_s41419_018_0444_x
crossref_primary_10_1016_j_bbcan_2020_188418
crossref_primary_10_1159_000515458
crossref_primary_10_3389_fphys_2020_00174
crossref_primary_10_1016_j_stem_2025_02_009
crossref_primary_10_1038_s41388_021_01858_7
crossref_primary_10_1177_10104283241313441
crossref_primary_10_1016_j_canlet_2022_216040
crossref_primary_10_1038_s41417_019_0146_2
crossref_primary_10_3892_etm_2018_6302
crossref_primary_10_1038_s41388_021_02140_6
crossref_primary_10_1111_cas_14794
crossref_primary_10_3389_fimmu_2024_1287459
crossref_primary_10_3389_fmolb_2022_833079
crossref_primary_10_3389_fonc_2019_00948
crossref_primary_10_1016_j_diff_2025_100860
crossref_primary_10_1016_j_gene_2023_147573
crossref_primary_10_1165_rcmb_2021_0257OC
crossref_primary_10_3892_ijo_2022_5406
crossref_primary_10_1002_1878_0261_13077
crossref_primary_10_1016_j_neulet_2024_137832
crossref_primary_10_3390_pharmaceutics14050988
crossref_primary_10_1016_j_prp_2020_153313
crossref_primary_10_1371_journal_pone_0255915
crossref_primary_10_1002_cjp2_205
crossref_primary_10_1002_cam4_1752
crossref_primary_10_1016_j_canlet_2019_07_015
crossref_primary_10_1248_cpb_c17_00582
crossref_primary_10_1016_j_bbrc_2019_05_167
crossref_primary_10_2174_1871520619666190730103425
crossref_primary_10_3389_fcell_2021_783617
crossref_primary_10_1186_s12885_019_6301_1
crossref_primary_10_3390_cancers12051347
crossref_primary_10_1007_s13224_023_01749_9
crossref_primary_10_1016_j_semcancer_2019_08_026
crossref_primary_10_14814_phy2_13907
crossref_primary_10_3390_cancers14215328
crossref_primary_10_4014_jmb_2110_10032
crossref_primary_10_1038_s41419_019_1376_9
crossref_primary_10_1158_0008_5472_CAN_18_2931
crossref_primary_10_1016_j_molmed_2023_03_002
crossref_primary_10_1016_j_dld_2019_09_013
crossref_primary_10_1016_j_omtn_2021_10_017
crossref_primary_10_3389_fbioe_2022_1025546
crossref_primary_10_3892_mmr_2018_8950
crossref_primary_10_1002_ctm2_670
crossref_primary_10_1042_BSR20181501
crossref_primary_10_1186_s12943_020_01300_8
crossref_primary_10_1186_s12917_024_04275_6
crossref_primary_10_1097_MD_0000000000032490
Cites_doi 10.4161/cbt.8.16.8961
10.1016/j.ccr.2013.01.023
10.3322/caac.21254
10.1101/gad.1228704
10.1074/jbc.M700522200
10.1158/1541-7786.MCR-12-0307
10.1016/j.canlet.2013.12.006
10.1016/j.cell.2011.11.025
10.1158/0008-5472.CAN-07-2477
10.1038/sj.onc.1209934
10.1038/nrc3023
10.1242/jcs.099697
10.1021/pr200527z
10.1007/s10495-012-0715-4
10.3109/17435390.2014.980760
10.1016/S0016-5085(98)70209-4
10.1186/1478-811X-9-18
10.18632/oncotarget.10471
10.1158/0008-5472.CAN-05-0779
10.1016/j.canlet.2010.03.003
10.1158/0008-5472.CAN-07-5714
10.1158/0008-5472.CAN-08-1132
10.3322/caac.21208
10.1046/j.1432-0436.2002.700904.x
10.1158/1078-0432.CCR-15-0256
10.1038/nature12626
10.1016/j.cell.2013.06.005
10.1097/00006676-200311000-00008
10.18632/oncotarget.3099
10.1038/35077241
10.1371/journal.pmed.1001871
10.18632/oncotarget.2398
10.1016/S0378-1119(01)00683-7
10.1038/onc.2013.584
10.1038/ncomms10715
10.1186/1476-4598-8-125
10.1002/ijc.11081
10.1074/jbc.M501625200
10.1042/BSR20130102
10.3389/fphys.2014.00088
ContentType Journal Article
Copyright 2017 Elsevier B.V.
Elsevier B.V.
Copyright © 2017 Elsevier B.V. All rights reserved.
Copyright Elsevier Limited Jul 10, 2017
Copyright_xml – notice: 2017 Elsevier B.V.
– notice: Elsevier B.V.
– notice: Copyright © 2017 Elsevier B.V. All rights reserved.
– notice: Copyright Elsevier Limited Jul 10, 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TO
7U9
H94
K9.
NAPCQ
7X8
DOI 10.1016/j.canlet.2017.04.001
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
DatabaseTitleList

AIDS and Cancer Research Abstracts
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1872-7980
EndPage 36
ExternalDocumentID 28400334
10_1016_j_canlet_2017_04_001
S0304383517302306
1_s2_0_S0304383517302306
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29B
4.4
457
4CK
4G.
5GY
5RE
5VS
6J9
6PF
7-5
71M
8FE
8FH
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABMZM
ABUDA
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACPRK
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADUVX
AEBSH
AEFWE
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKEYQ
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IH2
IHE
J1W
K-O
KOM
LK8
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
ROL
RPZ
SCC
SDF
SDG
SDP
SEL
SES
SPCBC
SSH
SSU
SSZ
T5K
Z5R
~G-
.55
.GJ
3O-
3V.
53G
7RV
7X7
8C1
8FI
AACTN
AAQXK
ABWVN
ABXDB
ACRPL
ADMUD
ADNMO
AFCTW
AFFNX
AFJKZ
AFKRA
AFKWA
AGRDE
AI.
AJOXV
AMFUW
ASPBG
AVWKF
AZFZN
AZQEC
BBNVY
BENPR
BHPHI
FEDTE
FGOYB
FYUFA
G-2
GUQSH
HCIFZ
HED
HMK
HMO
HVGLF
HZ~
M1P
M2M
M2O
M7P
R2-
RIG
SAE
SEW
UDS
VH1
WUQ
X7M
ZGI
AAIAV
ABLVK
ABYKQ
AJBFU
DOVZS
EFLBG
LCYCR
AAYXX
AGQPQ
AGRNS
AIGII
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TO
7U9
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c564t-73f31b0434a0a8fd4c321fe9e50ebfb5c08928049bfe0b5a5983732ca2d143de3
IEDL.DBID .~1
ISSN 0304-3835
1872-7980
IngestDate Fri Jul 11 05:34:20 EDT 2025
Wed Aug 13 06:10:26 EDT 2025
Wed Feb 19 02:42:08 EST 2025
Tue Jul 01 02:29:34 EDT 2025
Thu Apr 24 23:09:00 EDT 2025
Fri Feb 23 02:33:50 EST 2024
Tue Feb 25 20:11:25 EST 2025
Tue Aug 26 17:11:47 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Migration
MMPs
CM
TMAs
EMT
Invasion
ECM
PCC
ASC
SLRP
α-SMA
PDAC
CAFs
Asporin
Pancreatic cancer
PSCs
ATRA
conditioned medium
α-smooth muscle actin
pancreatic ductal adenocarcinoma
Tissue microarrays
matrix metalloproteinases
pancreatic stellate cells
all-trans retinoic acid
pancreatic cancer cell
cancer-associated fibroblasts
the American Cancer Society
small leucine-rich proteoglycan
extracellular matrix
Language English
License Copyright © 2017 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c564t-73f31b0434a0a8fd4c321fe9e50ebfb5c08928049bfe0b5a5983732ca2d143de3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 28400334
PQID 1895500467
PQPubID 2031080
PageCount 13
ParticipantIDs proquest_miscellaneous_1887051352
proquest_journals_1895500467
pubmed_primary_28400334
crossref_citationtrail_10_1016_j_canlet_2017_04_001
crossref_primary_10_1016_j_canlet_2017_04_001
elsevier_sciencedirect_doi_10_1016_j_canlet_2017_04_001
elsevier_clinicalkeyesjournals_1_s2_0_S0304383517302306
elsevier_clinicalkey_doi_10_1016_j_canlet_2017_04_001
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-07-10
PublicationDateYYYYMMDD 2017-07-10
PublicationDate_xml – month: 07
  year: 2017
  text: 2017-07-10
  day: 10
PublicationDecade 2010
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
– name: Clare
PublicationTitle Cancer letters
PublicationTitleAlternate Cancer Lett
PublicationYear 2017
Publisher Elsevier B.V
Elsevier Limited
Publisher_xml – name: Elsevier B.V
– name: Elsevier Limited
References Hurley, Sundi, Shinder, Simons, Hughes, Miller (bib10) 2016; 22
Satoyoshi, Kuriyama, Aiba, Yashiro, Tanaka (bib13) 2015; 34
Asano, Yao, Shin, McCubrey, Abbruzzese, Reddy (bib43) 2005; 65
Apte, Wilson (bib5) 2003; 27
Tyagi, Bhardwaj, Singh, McClellan, Carter, Singh (bib40) 2014; 5
Gos, Miloszewska, Przybyszewska (bib30) 2009; 55
Chaffer, Marjanovic, Lee, Bell, Kleer, Reinhardt (bib28) 2013; 154
Siegel, Ma, Zou, Jemal (bib3) 2014; 64
Junttila, de Sauvage (bib23) 2013; 501
Simkova, Kharaishvili, Korinkova, Ozdian, Suchankova-Kleplova, Soukup (bib27) 2016
Zoller (bib14) 2011; 11
Turtoi, Musmeci, Wang, Dumont, Somja, Bevilacqua (bib11) 2011; 10
Fidler (bib22) 2002; 70
Zhang, Wu, Guan, Wang, Ren, Shi (bib15) 2015; 6
Wu, Jing, Cheng, He, Hu, Wu (bib26) 2016
Gumireddy, Li, Kossenkov, Sakurai, Yan, Li (bib39) 2016; 7
Guan, Zhang, Wen, Gu, Cheng, Sun (bib16) 2014; 345
Shimobayashi, Hall (bib41) 2014; 15
Li, Zhang, Zheng, Guo (bib46) 2015; 8
Vonlaufen, Joshi, Qu, Phillips, Xu, Parker (bib7) 2008; 68
Fu, Feng, Zeng, Ding, Yu, Yang (bib38) 2014
Yang, Huang (bib19) 2005; 280
Chung, Vadgama (bib45) 2015; 35
Liptay, Weber, Ludwig, Wagner, Adler, Schmid (bib32) 2003; 105
Wharry, Haines, Carroll, May (bib33) 2009; 8
Kar, Palit, Ball, Das (bib37) 2012; 17
Hwang, Moore, Arumugam, Ramachandran, Amos, Rivera (bib4) 2008; 68
Liotta, Kohn (bib21) 2001; 411
Hayden, Ghosh (bib35) 2004; 18
Eser, Reiff, Messer, Seidler, Gottschalk, Dobler (bib42) 2013; 23
Nakajima, Kizawa, Saitoh, Kou, Miyazono, Ikegawa (bib9) 2007; 282
Huanwen, Zhiyong, Xiaohua, Xinyu, Kai, Tonghua (bib17) 2009; 8
Rhim, Mirek, Aiello, Maitra, Bailey, McAllister (bib29) 2012; 148
Albini, Iwamoto, Kleinman, Martin, Aaronson, Kozlowski (bib20) 1987; 47
Maris, Blomme, Palacios, Costanza, Bellahcene, Bianchi (bib12) 2015; 12
Bachem, Schneider, Gross, Weidenbach, Schmid, Menke (bib18) 1998; 115
Ungefroren, Sebens, Seidl, Lehnert, Hass (bib24) 2011; 9
Scheidereit (bib36) 2006; 25
Maier, Schmidt-Strassburger, Huber, Wiedemann, Beug, Wirth (bib34) 2010; 295
Tan, Yaffee, Jamil, Lo, Nissen, Pandol (bib1) 2014; 5
Karagiannis, Poutahidis, Erdman, Kirsch, Riddell, Diamandis (bib25) 2012; 10
Vonlaufen, Phillips, Xu, Goldstein, Pirola, Wilson (bib6) 2008; 68
Bohmert, Niemann, Lichtenstein, Juling, Lampen (bib44) 2015; 9
Siegel, Miller, Jemal (bib2) 2015; 65
Huang, Guilford, Thiery (bib31) 2012; 125
Yamada, Murakami, Matoba, Ozawa, Yokokoji, Nakahira (bib8) 2001; 275
Zoller (10.1016/j.canlet.2017.04.001_bib14) 2011; 11
Rhim (10.1016/j.canlet.2017.04.001_bib29) 2012; 148
Siegel (10.1016/j.canlet.2017.04.001_bib3) 2014; 64
Bohmert (10.1016/j.canlet.2017.04.001_bib44) 2015; 9
Yang (10.1016/j.canlet.2017.04.001_bib19) 2005; 280
Scheidereit (10.1016/j.canlet.2017.04.001_bib36) 2006; 25
Fidler (10.1016/j.canlet.2017.04.001_bib22) 2002; 70
Gos (10.1016/j.canlet.2017.04.001_bib30) 2009; 55
Nakajima (10.1016/j.canlet.2017.04.001_bib9) 2007; 282
Maris (10.1016/j.canlet.2017.04.001_bib12) 2015; 12
Maier (10.1016/j.canlet.2017.04.001_bib34) 2010; 295
Junttila (10.1016/j.canlet.2017.04.001_bib23) 2013; 501
Hwang (10.1016/j.canlet.2017.04.001_bib4) 2008; 68
Vonlaufen (10.1016/j.canlet.2017.04.001_bib6) 2008; 68
Zhang (10.1016/j.canlet.2017.04.001_bib15) 2015; 6
Chaffer (10.1016/j.canlet.2017.04.001_bib28) 2013; 154
Hurley (10.1016/j.canlet.2017.04.001_bib10) 2016; 22
Simkova (10.1016/j.canlet.2017.04.001_bib27) 2016
Huanwen (10.1016/j.canlet.2017.04.001_bib17) 2009; 8
Wharry (10.1016/j.canlet.2017.04.001_bib33) 2009; 8
Siegel (10.1016/j.canlet.2017.04.001_bib2) 2015; 65
Yamada (10.1016/j.canlet.2017.04.001_bib8) 2001; 275
Bachem (10.1016/j.canlet.2017.04.001_bib18) 1998; 115
Albini (10.1016/j.canlet.2017.04.001_bib20) 1987; 47
Satoyoshi (10.1016/j.canlet.2017.04.001_bib13) 2015; 34
Wu (10.1016/j.canlet.2017.04.001_bib26) 2016
Eser (10.1016/j.canlet.2017.04.001_bib42) 2013; 23
Huang (10.1016/j.canlet.2017.04.001_bib31) 2012; 125
Hayden (10.1016/j.canlet.2017.04.001_bib35) 2004; 18
Shimobayashi (10.1016/j.canlet.2017.04.001_bib41) 2014; 15
Li (10.1016/j.canlet.2017.04.001_bib46) 2015; 8
Tyagi (10.1016/j.canlet.2017.04.001_bib40) 2014; 5
Kar (10.1016/j.canlet.2017.04.001_bib37) 2012; 17
Turtoi (10.1016/j.canlet.2017.04.001_bib11) 2011; 10
Karagiannis (10.1016/j.canlet.2017.04.001_bib25) 2012; 10
Asano (10.1016/j.canlet.2017.04.001_bib43) 2005; 65
Ungefroren (10.1016/j.canlet.2017.04.001_bib24) 2011; 9
Fu (10.1016/j.canlet.2017.04.001_bib38) 2014
Tan (10.1016/j.canlet.2017.04.001_bib1) 2014; 5
Liotta (10.1016/j.canlet.2017.04.001_bib21) 2001; 411
Liptay (10.1016/j.canlet.2017.04.001_bib32) 2003; 105
Gumireddy (10.1016/j.canlet.2017.04.001_bib39) 2016; 7
Apte (10.1016/j.canlet.2017.04.001_bib5) 2003; 27
Vonlaufen (10.1016/j.canlet.2017.04.001_bib7) 2008; 68
Guan (10.1016/j.canlet.2017.04.001_bib16) 2014; 345
Chung (10.1016/j.canlet.2017.04.001_bib45) 2015; 35
References_xml – volume: 65
  start-page: 5
  year: 2015
  end-page: 29
  ident: bib2
  article-title: Cancer statistics, 2015
  publication-title: CA Cancer J. Clin.
– volume: 9
  start-page: 18
  year: 2011
  ident: bib24
  article-title: Interaction of tumor cells with the microenvironment
  publication-title: Cell Commun. Signal. CCS
– volume: 125
  start-page: 4417
  year: 2012
  end-page: 4422
  ident: bib31
  article-title: Early events in cell adhesion and polarity during epithelial-mesenchymal transition
  publication-title: J. Cell Sci.
– volume: 5
  start-page: 8778
  year: 2014
  end-page: 8789
  ident: bib40
  article-title: p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-kappaB pathway
  publication-title: Oncotarget
– volume: 295
  start-page: 214
  year: 2010
  end-page: 228
  ident: bib34
  article-title: NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells
  publication-title: Cancer Lett.
– volume: 5
  start-page: 88
  year: 2014
  ident: bib1
  article-title: Pancreatic cancer cachexia: a review of mechanisms and therapeutics
  publication-title: Front. Physiol.
– volume: 282
  start-page: 32185
  year: 2007
  end-page: 32192
  ident: bib9
  article-title: Mechanisms for asporin function and regulation in articular cartilage
  publication-title: J. Biol. Chem.
– volume: 275
  start-page: 279
  year: 2001
  end-page: 286
  ident: bib8
  article-title: Expression profile of active genes in human periodontal ligament and isolation of PLAP-1, a novel SLRP family gene
  publication-title: Gene
– volume: 34
  start-page: 650
  year: 2015
  end-page: 660
  ident: bib13
  article-title: Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts
  publication-title: Oncogene
– volume: 8
  start-page: 6724
  year: 2015
  end-page: 6731
  ident: bib46
  article-title: Expression of CD44 in pancreatic cancer and its significance
  publication-title: Int. J. Clin. Exp. Pathol.
– volume: 8
  start-page: 125
  year: 2009
  ident: bib17
  article-title: Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines
  publication-title: Mol. Cancer
– volume: 7
  start-page: 10715
  year: 2016
  ident: bib39
  article-title: The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis
  publication-title: Nat. Commun.
– volume: 65
  start-page: 9164
  year: 2005
  end-page: 9168
  ident: bib43
  article-title: Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells
  publication-title: Cancer Res.
– volume: 22
  start-page: 448
  year: 2016
  end-page: 458
  ident: bib10
  article-title: Germline variants in asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancer
  publication-title: Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res.
– year: 2016
  ident: bib26
  article-title: Asporin enhances colorectal cancer metastasis through activating the EGFR/src/cortactin signaling pathway
  publication-title: Oncotarget
– volume: 64
  start-page: 9
  year: 2014
  end-page: 29
  ident: bib3
  article-title: Cancer statistics, 2014
  publication-title: CA Cancer J. Clin.
– volume: 55
  start-page: 121
  year: 2009
  end-page: 128
  ident: bib30
  article-title: Epithelial-mesenchymal transition in cancer progression
  publication-title: Postep. Biochem.
– volume: 68
  start-page: 2085
  year: 2008
  end-page: 2093
  ident: bib7
  article-title: Pancreatic stellate cells: partners in crime with pancreatic cancer cells
  publication-title: Cancer Res.
– volume: 11
  start-page: 254
  year: 2011
  end-page: 267
  ident: bib14
  article-title: CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
  publication-title: Nat. Rev. Cancer
– volume: 27
  start-page: 316
  year: 2003
  end-page: 320
  ident: bib5
  article-title: Stellate cell activation in alcoholic pancreatitis
  publication-title: Pancreas
– volume: 68
  start-page: 918
  year: 2008
  end-page: 926
  ident: bib4
  article-title: Cancer-associated stromal fibroblasts promote pancreatic tumor progression
  publication-title: Cancer Res.
– volume: 12
  start-page: e1001871
  year: 2015
  ident: bib12
  article-title: Asporin is a fibroblast-derived TGF-beta1 inhibitor and a tumor suppressor associated with good prognosis in breast cancer
  publication-title: PLoS Med.
– volume: 8
  start-page: 1567
  year: 2009
  end-page: 1576
  ident: bib33
  article-title: Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells
  publication-title: Cancer Biol. Ther.
– volume: 15
  start-page: 155
  year: 2014
  end-page: 162
  ident: bib41
  article-title: Making new contacts: the mTOR network in metabolism and signalling crosstalk, Nature reviews
  publication-title: Mol. Cell Biol.
– volume: 68
  start-page: 7707
  year: 2008
  end-page: 7710
  ident: bib6
  article-title: Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance
  publication-title: Cancer Res.
– volume: 280
  start-page: 27130
  year: 2005
  end-page: 27137
  ident: bib19
  article-title: Ca2+ influx through L-type Ca2+ channels controls the trailing tail contraction in growth factor-induced fibroblast cell migration
  publication-title: J. Biol. Chem.
– volume: 10
  start-page: 1403
  year: 2012
  end-page: 1418
  ident: bib25
  article-title: Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue
  publication-title: Mol. Cancer Res. MCR
– volume: 115
  start-page: 421
  year: 1998
  end-page: 432
  ident: bib18
  article-title: Identification, culture, and characterization of pancreatic stellate cells in rats and humans
  publication-title: Gastroenterology
– volume: 345
  start-page: 132
  year: 2014
  end-page: 139
  ident: bib16
  article-title: Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells
  publication-title: Cancer Lett.
– volume: 105
  start-page: 735
  year: 2003
  end-page: 746
  ident: bib32
  article-title: Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer
  publication-title: Int. J. Cancer
– volume: 25
  start-page: 6685
  year: 2006
  end-page: 6705
  ident: bib36
  article-title: IkappaB kinase complexes: gateways to NF-kappaB activation and transcription
  publication-title: Oncogene
– volume: 9
  start-page: 852
  year: 2015
  end-page: 860
  ident: bib44
  article-title: Molecular mechanism of silver nanoparticles in human intestinal cells
  publication-title: Nanotoxicology
– volume: 35
  start-page: 39
  year: 2015
  end-page: 46
  ident: bib45
  article-title: Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFkappaB signaling
  publication-title: Anticancer Res.
– volume: 47
  start-page: 3239
  year: 1987
  end-page: 3245
  ident: bib20
  article-title: A rapid in vitro assay for quantitating the invasive potential of tumor cells
  publication-title: Cancer Res.
– volume: 501
  start-page: 346
  year: 2013
  end-page: 354
  ident: bib23
  article-title: Influence of tumour micro-environment heterogeneity on therapeutic response
  publication-title: Nature
– volume: 148
  start-page: 349
  year: 2012
  end-page: 361
  ident: bib29
  article-title: EMT and dissemination precede pancreatic tumor formation
  publication-title: Cell
– year: 2016
  ident: bib27
  article-title: The dual role of asporin in breast cancer progression
  publication-title: Oncotarget
– volume: 18
  start-page: 2195
  year: 2004
  end-page: 2224
  ident: bib35
  article-title: Signaling to NF-kappaB
  publication-title: Genes Dev.
– volume: 17
  start-page: 735
  year: 2012
  end-page: 747
  ident: bib37
  article-title: Carnosic acid modulates Akt/IKK/NF-kappaB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells
  publication-title: Apoptosis Int. J. Program. Cell Death
– volume: 23
  start-page: 406
  year: 2013
  end-page: 420
  ident: bib42
  article-title: Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer
  publication-title: Cancer Cell
– volume: 411
  start-page: 375
  year: 2001
  end-page: 379
  ident: bib21
  article-title: The microenvironment of the tumour-host interface
  publication-title: Nature
– volume: 6
  start-page: 3085
  year: 2015
  end-page: 3097
  ident: bib15
  article-title: Paracrine SDF-1alpha signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells
  publication-title: Oncotarget
– volume: 70
  start-page: 498
  year: 2002
  end-page: 505
  ident: bib22
  article-title: The organ microenvironment and cancer metastasis
  publication-title: Differ. Res. Biol. Divers.
– volume: 154
  start-page: 61
  year: 2013
  end-page: 74
  ident: bib28
  article-title: Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity
  publication-title: Cell
– volume: 10
  start-page: 4302
  year: 2011
  end-page: 4313
  ident: bib11
  article-title: Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma
  publication-title: J. Proteome Res.
– year: 2014
  ident: bib38
  article-title: PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/Erk-dependent pathways
  publication-title: Biosci. Rep.
– volume: 8
  start-page: 1567
  year: 2009
  ident: 10.1016/j.canlet.2017.04.001_bib33
  article-title: Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells
  publication-title: Cancer Biol. Ther.
  doi: 10.4161/cbt.8.16.8961
– volume: 15
  start-page: 155
  year: 2014
  ident: 10.1016/j.canlet.2017.04.001_bib41
  article-title: Making new contacts: the mTOR network in metabolism and signalling crosstalk, Nature reviews
  publication-title: Mol. Cell Biol.
– volume: 23
  start-page: 406
  year: 2013
  ident: 10.1016/j.canlet.2017.04.001_bib42
  article-title: Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.01.023
– volume: 65
  start-page: 5
  year: 2015
  ident: 10.1016/j.canlet.2017.04.001_bib2
  article-title: Cancer statistics, 2015
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21254
– volume: 18
  start-page: 2195
  year: 2004
  ident: 10.1016/j.canlet.2017.04.001_bib35
  article-title: Signaling to NF-kappaB
  publication-title: Genes Dev.
  doi: 10.1101/gad.1228704
– volume: 55
  start-page: 121
  year: 2009
  ident: 10.1016/j.canlet.2017.04.001_bib30
  article-title: Epithelial-mesenchymal transition in cancer progression
  publication-title: Postep. Biochem.
– volume: 282
  start-page: 32185
  year: 2007
  ident: 10.1016/j.canlet.2017.04.001_bib9
  article-title: Mechanisms for asporin function and regulation in articular cartilage
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M700522200
– volume: 10
  start-page: 1403
  year: 2012
  ident: 10.1016/j.canlet.2017.04.001_bib25
  article-title: Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue
  publication-title: Mol. Cancer Res. MCR
  doi: 10.1158/1541-7786.MCR-12-0307
– volume: 345
  start-page: 132
  year: 2014
  ident: 10.1016/j.canlet.2017.04.001_bib16
  article-title: Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2013.12.006
– volume: 148
  start-page: 349
  year: 2012
  ident: 10.1016/j.canlet.2017.04.001_bib29
  article-title: EMT and dissemination precede pancreatic tumor formation
  publication-title: Cell
  doi: 10.1016/j.cell.2011.11.025
– volume: 68
  start-page: 2085
  year: 2008
  ident: 10.1016/j.canlet.2017.04.001_bib7
  article-title: Pancreatic stellate cells: partners in crime with pancreatic cancer cells
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-2477
– volume: 25
  start-page: 6685
  year: 2006
  ident: 10.1016/j.canlet.2017.04.001_bib36
  article-title: IkappaB kinase complexes: gateways to NF-kappaB activation and transcription
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209934
– volume: 11
  start-page: 254
  year: 2011
  ident: 10.1016/j.canlet.2017.04.001_bib14
  article-title: CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3023
– volume: 125
  start-page: 4417
  year: 2012
  ident: 10.1016/j.canlet.2017.04.001_bib31
  article-title: Early events in cell adhesion and polarity during epithelial-mesenchymal transition
  publication-title: J. Cell Sci.
  doi: 10.1242/jcs.099697
– volume: 10
  start-page: 4302
  year: 2011
  ident: 10.1016/j.canlet.2017.04.001_bib11
  article-title: Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma
  publication-title: J. Proteome Res.
  doi: 10.1021/pr200527z
– volume: 35
  start-page: 39
  year: 2015
  ident: 10.1016/j.canlet.2017.04.001_bib45
  article-title: Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFkappaB signaling
  publication-title: Anticancer Res.
– volume: 17
  start-page: 735
  year: 2012
  ident: 10.1016/j.canlet.2017.04.001_bib37
  article-title: Carnosic acid modulates Akt/IKK/NF-kappaB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells
  publication-title: Apoptosis Int. J. Program. Cell Death
  doi: 10.1007/s10495-012-0715-4
– volume: 9
  start-page: 852
  year: 2015
  ident: 10.1016/j.canlet.2017.04.001_bib44
  article-title: Molecular mechanism of silver nanoparticles in human intestinal cells
  publication-title: Nanotoxicology
  doi: 10.3109/17435390.2014.980760
– volume: 8
  start-page: 6724
  year: 2015
  ident: 10.1016/j.canlet.2017.04.001_bib46
  article-title: Expression of CD44 in pancreatic cancer and its significance
  publication-title: Int. J. Clin. Exp. Pathol.
– volume: 115
  start-page: 421
  year: 1998
  ident: 10.1016/j.canlet.2017.04.001_bib18
  article-title: Identification, culture, and characterization of pancreatic stellate cells in rats and humans
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(98)70209-4
– volume: 9
  start-page: 18
  year: 2011
  ident: 10.1016/j.canlet.2017.04.001_bib24
  article-title: Interaction of tumor cells with the microenvironment
  publication-title: Cell Commun. Signal. CCS
  doi: 10.1186/1478-811X-9-18
– year: 2016
  ident: 10.1016/j.canlet.2017.04.001_bib27
  article-title: The dual role of asporin in breast cancer progression
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.10471
– volume: 65
  start-page: 9164
  year: 2005
  ident: 10.1016/j.canlet.2017.04.001_bib43
  article-title: Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-05-0779
– volume: 47
  start-page: 3239
  year: 1987
  ident: 10.1016/j.canlet.2017.04.001_bib20
  article-title: A rapid in vitro assay for quantitating the invasive potential of tumor cells
  publication-title: Cancer Res.
– volume: 295
  start-page: 214
  year: 2010
  ident: 10.1016/j.canlet.2017.04.001_bib34
  article-title: NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2010.03.003
– volume: 68
  start-page: 918
  year: 2008
  ident: 10.1016/j.canlet.2017.04.001_bib4
  article-title: Cancer-associated stromal fibroblasts promote pancreatic tumor progression
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-5714
– volume: 68
  start-page: 7707
  year: 2008
  ident: 10.1016/j.canlet.2017.04.001_bib6
  article-title: Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-08-1132
– volume: 64
  start-page: 9
  year: 2014
  ident: 10.1016/j.canlet.2017.04.001_bib3
  article-title: Cancer statistics, 2014
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21208
– volume: 70
  start-page: 498
  year: 2002
  ident: 10.1016/j.canlet.2017.04.001_bib22
  article-title: The organ microenvironment and cancer metastasis
  publication-title: Differ. Res. Biol. Divers.
  doi: 10.1046/j.1432-0436.2002.700904.x
– volume: 22
  start-page: 448
  year: 2016
  ident: 10.1016/j.canlet.2017.04.001_bib10
  article-title: Germline variants in asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancer
  publication-title: Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-0256
– volume: 501
  start-page: 346
  year: 2013
  ident: 10.1016/j.canlet.2017.04.001_bib23
  article-title: Influence of tumour micro-environment heterogeneity on therapeutic response
  publication-title: Nature
  doi: 10.1038/nature12626
– volume: 154
  start-page: 61
  year: 2013
  ident: 10.1016/j.canlet.2017.04.001_bib28
  article-title: Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity
  publication-title: Cell
  doi: 10.1016/j.cell.2013.06.005
– volume: 27
  start-page: 316
  year: 2003
  ident: 10.1016/j.canlet.2017.04.001_bib5
  article-title: Stellate cell activation in alcoholic pancreatitis
  publication-title: Pancreas
  doi: 10.1097/00006676-200311000-00008
– volume: 6
  start-page: 3085
  year: 2015
  ident: 10.1016/j.canlet.2017.04.001_bib15
  article-title: Paracrine SDF-1alpha signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3099
– volume: 411
  start-page: 375
  year: 2001
  ident: 10.1016/j.canlet.2017.04.001_bib21
  article-title: The microenvironment of the tumour-host interface
  publication-title: Nature
  doi: 10.1038/35077241
– volume: 12
  start-page: e1001871
  year: 2015
  ident: 10.1016/j.canlet.2017.04.001_bib12
  article-title: Asporin is a fibroblast-derived TGF-beta1 inhibitor and a tumor suppressor associated with good prognosis in breast cancer
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.1001871
– volume: 5
  start-page: 8778
  year: 2014
  ident: 10.1016/j.canlet.2017.04.001_bib40
  article-title: p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-kappaB pathway
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.2398
– volume: 275
  start-page: 279
  year: 2001
  ident: 10.1016/j.canlet.2017.04.001_bib8
  article-title: Expression profile of active genes in human periodontal ligament and isolation of PLAP-1, a novel SLRP family gene
  publication-title: Gene
  doi: 10.1016/S0378-1119(01)00683-7
– volume: 34
  start-page: 650
  year: 2015
  ident: 10.1016/j.canlet.2017.04.001_bib13
  article-title: Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts
  publication-title: Oncogene
  doi: 10.1038/onc.2013.584
– volume: 7
  start-page: 10715
  year: 2016
  ident: 10.1016/j.canlet.2017.04.001_bib39
  article-title: The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms10715
– volume: 8
  start-page: 125
  year: 2009
  ident: 10.1016/j.canlet.2017.04.001_bib17
  article-title: Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-8-125
– volume: 105
  start-page: 735
  year: 2003
  ident: 10.1016/j.canlet.2017.04.001_bib32
  article-title: Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.11081
– volume: 280
  start-page: 27130
  year: 2005
  ident: 10.1016/j.canlet.2017.04.001_bib19
  article-title: Ca2+ influx through L-type Ca2+ channels controls the trailing tail contraction in growth factor-induced fibroblast cell migration
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M501625200
– year: 2014
  ident: 10.1016/j.canlet.2017.04.001_bib38
  article-title: PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/Erk-dependent pathways
  publication-title: Biosci. Rep.
  doi: 10.1042/BSR20130102
– volume: 5
  start-page: 88
  year: 2014
  ident: 10.1016/j.canlet.2017.04.001_bib1
  article-title: Pancreatic cancer cachexia: a review of mechanisms and therapeutics
  publication-title: Front. Physiol.
  doi: 10.3389/fphys.2014.00088
– year: 2016
  ident: 10.1016/j.canlet.2017.04.001_bib26
  article-title: Asporin enhances colorectal cancer metastasis through activating the EGFR/src/cortactin signaling pathway
  publication-title: Oncotarget
SSID ssj0005475
Score 2.501383
Snippet Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular matrix...
Abstract Pancreatic cancer is histopathologically characterized by excessive desmoplasia induced by pancreatic stellate cells (PSCs). Asporin, an extracellular...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 24
SubjectTerms Aged
AKT protein
Asporin
Autocrine Communication
Autocrine signalling
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Biotechnology
Breast cancer
CD44 antigen
Cell Line, Tumor
Cell Proliferation
EMT
Epithelial-Mesenchymal Transition
Extracellular matrix
Extracellular Matrix Proteins - genetics
Extracellular Matrix Proteins - metabolism
Extracellular Signal-Regulated MAP Kinases - metabolism
Female
Fibroblasts
Gene expression
Hematology, Oncology and Palliative Medicine
Humans
Hyaluronan Receptors - metabolism
Invasion
Kinases
Male
Mesenchyme
Metabolic pathways
Metastasis
Middle Aged
Migration
Neoplasm Invasiveness
Pancreatic cancer
Pancreatic Neoplasms - genetics
Pancreatic Neoplasms - metabolism
Pancreatic Neoplasms - pathology
Pancreatic Stellate Cells - metabolism
Pancreatic Stellate Cells - pathology
Paracrine Communication
Paracrine signalling
Penicillin
Phosphorylation
Proteins
Proto-Oncogene Proteins c-akt - metabolism
RNA Interference
Signal Transduction
Stellate cells
Stroma
Stromal Cells - metabolism
Stromal Cells - pathology
Transcription Factor RelA - metabolism
Transfection
Tumor Microenvironment
Title Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0304383517302306
https://www.clinicalkey.es/playcontent/1-s2.0-S0304383517302306
https://dx.doi.org/10.1016/j.canlet.2017.04.001
https://www.ncbi.nlm.nih.gov/pubmed/28400334
https://www.proquest.com/docview/1895500467
https://www.proquest.com/docview/1887051352
Volume 398
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIiEuiDdLS2UkDnAw68T2JntcVa0W0PZCK_Vm2Y4DqZrsapOt1At_iD_JjOMsRRQVcXRiy5ZnPPONPQ9C3kqVFEbkE1YmXDApfYbvuylDqOBNaW0eklUvTibzM_npXJ3vkMMhFgbdKqPs72V6kNbxyzju5nhVVeMv-KgH9pVKMhGANEawywy5_MP3G24eMiTbxc4Mew_hc8HHC1YPu4MOXllIeBpLw9yinv4GP4MaOn5EHkb8SGf9Eh-THd88IfcX8YX8KfkxQzu1augq-Nn5lsJx75Ghow5JvKZ4WU-r5srgTRk1TUHr6mvPCdRe03Vfnh50GgV0SP0KwzYugU9Zt2Q1Riu5b9c1LKJDPRdcvui7o8XpexqL_lAL5Kdm0y0dxhaGGTDFeN-qPQYbV23dPiNnx0enh3MWCzIwpyayY5koRWJh16XhJi8L6USalH7qFfe2tMrxfJrmYHPY0nOrjJqC-StSZ9ICYFnhxXOy2ywb_5LQLPWFcgkYlxMlSy9NyZ0B4yUVIDBk4UdEDHTQLmYrx6IZl3pwS7vQPfU0Uk9zid55I8K2o1Z9to47-quBxHqIRAXZqUGd3DEuu22cb6MAaHWi21Rz_QeT3hz5G5__w5z7Aw_qX9PkUzAxOWi7EXmz_Q0SAjnJNH65wT4gk1UCSHtEXvS8u90cACdYzU---u9l7ZEH2MLr7oTvk91uvfGvAad19iAcxANyb_bx8_zkJ2Q2Psg
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdGJwEviG8KA4zEAzxYdWK7SR-raVPH1r7QSXuzbMeBoCWtmhRpfxP_JHeJ04EYGuKxjU92fJe739n3Qch7qaLMiHTM8ogLJqVP8H43ZggVvMmtTdti1fPFeHYuP12oiz1y2OfCYFhl0P2dTm-1dfhnFHZztC6K0We81AP_SkWJaIH0HbKP1anUgOxPT05ni-tID9nW28XxDAn6DLo2zAteADYIY7yStuZp6A5zg4X6GwJtLdHxQ_IgQEg67Vb5iOz56jG5Ow-X5E_Ijym6qkVF122ona8pfPEdOHTUIZc3FM_raVF9N3hYRk2V0bL40gkDtVd003WoB7NGASBSv8bMjUsQVdasWIkJS-7rVQmLaNDUtVFf9MPRfPmRhr4_1IIEULNtVg7TC9sZsMp496v0mG9c1GX9lJwfHy0PZyz0ZGBOjWXDEpGLyMLGS8NNmmfSiTjK_cQr7m1ulePpJE7B7bC551YZNQEPWMTOxBkgs8yLZ2RQrSr_gtAk9plyEfiXYyVzL03OnQH_JRagM2Tmh0T0fNAuFCzHvhmXuo9M-6Y77mnknuYSA_SGhO2o1l3BjlvGq57Fuk9GBfWpwaLcQpfcROfroANqHek61lz_Iae_Uv4m6v8w50Evg_p6mnQCXiYHgzck73aPQUmgJJnKr7Y4BtSyigBsD8nzTnZ3mwP4BBv6yZf_vay35N5sOT_TZyeL01fkPj7B0--IH5BBs9n61wDbGvsmfJY_ASfFQXk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Asporin+promotes+pancreatic+cancer+cell+invasion+and+migration+by+regulating+the+epithelial-to-mesenchymal+transition+%28EMT%29+through+both+autocrine+and+paracrine+mechanisms&rft.jtitle=Cancer+letters&rft.au=Wang%2C+Lili&rft.au=Wu%2C+Huanwen&rft.au=Wang%2C+Li&rft.au=Zhang%2C+Hui&rft.date=2017-07-10&rft.eissn=1872-7980&rft.volume=398&rft.spage=24&rft_id=info:doi/10.1016%2Fj.canlet.2017.04.001&rft_id=info%3Apmid%2F28400334&rft.externalDocID=28400334
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-3835&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-3835&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-3835&client=summon